| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
in Adipocytes
The Third Department of Internal Medicine (K.K., T.M., A.M., M.I., Y.Kan., Y.Kaw., Y.N., K.Y.) and Department of General Medicine (T.I.), Gifu University School of Medicine, Tsukasa-machi 40, Gifu 500-8705, Japan
Address all correspondence and requests for reprints to: Tatsuo Ishizuka, Department of General Medicine, Gifu University School of Medicine, Tsukasa-Machi 40, Gifu 500-8705, Japan. E-mail: tishizuk-gif{at}umin.ac.jp.
Dehydroepiandrosterone (DHEA) is expected to have a weight-reducing effect. In this study, we evaluated the effect of DHEA on genetically obese Otsuka Long Evans Fatty rats (OLETF) compared with Long-Evans Tokushima rats (LETO) as control. Feeding with 0.4% DHEA-containing food for 2 wk reduced the weight of sc, epididymal, and perirenal adipose tissue in association with decreased plasma leptin levels in OLETF. Adipose tissue from OLETF showed increased expression of peroxisome proliferator-activated receptor
(PPAR
) protein, which was prevented by DHEA treatment. Further, we examined the effect of DHEA on PPAR
in primary cultured adipocytes and monolayer adipocytes differentiated from rat preadipocytes. PPAR
protein level was decreased in a time- and concentration-dependent manner, and DHEA significantly reduced mRNA levels of PPAR
, adipocyte lipid-binding protein, and sterol regulatory element-binding protein, but not CCAAT/enhancer binding protein
. DHEA-sulfate also reduced the PPAR
protein, but dexamethasone, testosterone, or androstenedione did not alter its expression. In addition, treatment with DHEA for 5 d reduced the triglyceride content in monolayer adipocytes. These results suggest that DHEA down-regulates adiposity through the reduction of PPAR
in adipocytes.
This article has been cited by other articles:
![]() |
M. Aragno, R. Mastrocola, C. Medana, F. Restivo, M. G. Catalano, N. Pons, O. Danni, and G. Boccuzzi Up-Regulation of Advanced Glycated Products Receptors in the Brain of Diabetic Rats Is Prevented by Antioxidant Treatment Endocrinology, December 1, 2005; 146(12): 5561 - 5567. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gosmain, N. Dif, V. Berbe, E. Loizon, J. Rieusset, H. Vidal, and E. Lefai Regulation of SREBP-1 expression and transcriptional action on HKII and FAS genes during fasting and refeeding in rat tissues J. Lipid Res., April 1, 2005; 46(4): 697 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dhatariya, M. L. Bigelow, and K. S. Nair Effect of Dehydroepiandrosterone Replacement on Insulin Sensitivity and Lipids in Hypoadrenal Women Diabetes, March 1, 2005; 54(3): 765 - 769. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |